New insights on neuronal nicotinic acetylcholine receptors as targets for pain and inflammation: A focus on α7 nAChRs
dc.contributor.author | Flood, Pamela | |
dc.contributor.author | Papke, Roger L. | |
dc.contributor.author | Damaj, M. Imad | |
dc.contributor.buuauthor | Bağdaş, Deniz | |
dc.contributor.buuauthor | Gürün, Mine Sibel | |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Deney Hayvanları Yetiştirme ve Araştırma Merkezi. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Farmakoloji Anabilim Dalı. | tr_TR |
dc.contributor.researcherid | AAG-8716-2019 | |
dc.contributor.researcherid | EOB-5882-2022 | |
dc.contributor.scopusid | 15062425700 | tr_TR |
dc.contributor.scopusid | 55664349700 | tr_TR |
dc.date.accessioned | 2024-03-28T10:54:20Z | |
dc.date.available | 2024-03-28T10:54:20Z | |
dc.date.issued | 2017-08-16 | |
dc.description.abstract | Background: Nicotine and nicotinic acetylcholine receptors (nAChRs) have been explored for the past three decades as targets for pain control. The aim of this review is to introduce readers particularly to alpha 7 nAChRs in a perspective of pain and its modulation. Methods: Developments for alpha 7 nAChR modulators and recent animal studies related to pain are reviewed. Results: Accumulating evidences suggest that selective ligands for alpha 7 nAChRs hold promise in the treatment of chronic pain conditions as they lack many of side effects associated with other nicotinic receptor types. Conclusion: This review provides the reader recent insights on alpha 7 nAChRs from structure and function to the latest findings on the pharmacology and therapeutic targeting of these receptors for the treatment of pain and inflammation. | en_US |
dc.description.sponsorship | United States Department of Health & Human Services - National Institutes of Health (NIH) - R01-CA206028 / R01GM057481 | en_US |
dc.identifier.citation | Bağdaş, D. vd. (2018). ''New insights on neuronal nicotinic acetylcholine receptors as targets for pain and inflammation: A focus on α7 nAChRs''. Current Neuropharmacology, 16(4), 415-425. | en_US |
dc.identifier.doi | https://doi.org/10.2174/1570159X15666170818102108 | |
dc.identifier.eissn | 1875-6190 | |
dc.identifier.endpage | 425 | tr_TR |
dc.identifier.issn | 1570-159X | |
dc.identifier.issue | 4 | tr_TR |
dc.identifier.pubmed | 28820052 | tr_TR |
dc.identifier.scopus | 2-s2.0-85048949626 | |
dc.identifier.startpage | 415 | tr_TR |
dc.identifier.uri | https://www.eurekaselect.com/article/85349 | en_US |
dc.identifier.uri | https://hdl.handle.net/11452/40650 | |
dc.identifier.volume | 16 | tr_TR |
dc.identifier.wos | 000431914200007 | tr_TR |
dc.indexed.wos | SCIE | en_US |
dc.language.iso | en | en_US |
dc.publisher | Bentham Science Publishers | en_US |
dc.relation.bap | (KUAP (T) 2016/15) | tr_TR |
dc.relation.collaboration | Yurt dışı | tr_TR |
dc.relation.journal | Current Neuropharmacology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Alpha 7 nicotinic acetylcholine receptors | en_US |
dc.subject | Nicotine | en_US |
dc.subject | Pain | en_US |
dc.subject | Inflammation | en_US |
dc.subject | Modulators | en_US |
dc.subject | Anti-inflammatory | en_US |
dc.subject | Agonists | en_US |
dc.subject | Positive allosteric modulator | en_US |
dc.subject | Cholinergic antiinflammatory pathway | en_US |
dc.subject | Gated ion-channel | en_US |
dc.subject | X-ray-structure | en_US |
dc.subject | Neuropathic pain | en_US |
dc.subject | Animal-models | en_US |
dc.subject | Spinal-cord | en_US |
dc.subject | Binding-sites | en_US |
dc.subject | Human monocytes | en_US |
dc.subject | Drug discovery | en_US |
dc.subject | Neurosciences & neurology | en_US |
dc.subject | Pharmacology & pharmacy | en_US |
dc.subject.emtree | Bungarotoxin receptor | en_US |
dc.subject.emtree | Gelatinase B | en_US |
dc.subject.emtree | Glial fibrillary acidic protein | en_US |
dc.subject.emtree | High mobility group B1 protein | en_US |
dc.subject.emtree | L kappa B | en_US |
dc.subject.emtree | Immunoglobulin enhancer binding protein | en_US |
dc.subject.emtree | Interleukin 1 | en_US |
dc.subject.emtree | Interleukin 10 | en_US |
dc.subject.emtree | Interleukin 18 | en_US |
dc.subject.emtree | Interleukin 1beta | en_US |
dc.subject.emtree | Interleukin 6 | en_US |
dc.subject.emtree | Janus kinase 2 | en_US |
dc.subject.emtree | Ligand gated ion channel | en_US |
dc.subject.emtree | Mecamylamine | en_US |
dc.subject.emtree | Mitogen activated protein kinase 1 | en_US |
dc.subject.emtree | Mitogen activated protein kinase 3 | en_US |
dc.subject.emtree | Myeloid differentiation factor 88 | en_US |
dc.subject.emtree | Nicotinic receptor | en_US |
dc.subject.emtree | Phosphatidylcholine | en_US |
dc.subject.emtree | Serotonin | en_US |
dc.subject.emtree | STAT3 protein | en_US |
dc.subject.emtree | Suppressor of cytokine signaling 3 | en_US |
dc.subject.emtree | Toll like receptor 4 | en_US |
dc.subject.emtree | Tumor necrosis factor | en_US |
dc.subject.emtree | Analgesic agent | en_US |
dc.subject.emtree | Cholinergic receptor stimulating agent | en_US |
dc.subject.emtree | Nicotinic receptor | en_US |
dc.subject.emtree | Nonsteroid antiinflammatory agent | en_US |
dc.subject.emtree | Antiinflammatory activity | en_US |
dc.subject.emtree | Binding site | en_US |
dc.subject.emtree | Chronic pain | en_US |
dc.subject.emtree | Conformational transition | en_US |
dc.subject.emtree | Cytokine production | en_US |
dc.subject.emtree | Cytokine release | en_US |
dc.subject.emtree | Desensitization | en_US |
dc.subject.emtree | Down regulation | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Inflammation | en_US |
dc.subject.emtree | Macrophage migration | en_US |
dc.subject.emtree | Neuropathic pain | en_US |
dc.subject.emtree | Nonhuman | en_US |
dc.subject.emtree | Pain | en_US |
dc.subject.emtree | Phosphorylation | en_US |
dc.subject.emtree | Protein expression | en_US |
dc.subject.emtree | Review | en_US |
dc.subject.emtree | Signal transduction | en_US |
dc.subject.emtree | Upregulation | en_US |
dc.subject.emtree | Animal | en_US |
dc.subject.emtree | Drug effect | en_US |
dc.subject.emtree | Inflammation | en_US |
dc.subject.emtree | Metabolism | en_US |
dc.subject.emtree | Nerve cell | en_US |
dc.subject.emtree | Pain | en_US |
dc.subject.mesh | Analgesics | en_US |
dc.subject.mesh | Animals | en_US |
dc.subject.mesh | Anti-inflammatory agents | en_US |
dc.subject.mesh | Non-steroidal | en_US |
dc.subject.mesh | Cholinergic agents | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Inflammation | en_US |
dc.subject.mesh | Neurons | en_US |
dc.subject.mesh | Pain | en_US |
dc.subject.mesh | Receptors, nicotinic | en_US |
dc.subject.scopus | Inflammation; Methyllycaconitine; 3-(2,4-Dimethoxybenzylidene)Anabaseine | en_US |
dc.subject.wos | Neurosciences | en_US |
dc.subject.wos | Pharmacology & pharmacy | en_US |
dc.title | New insights on neuronal nicotinic acetylcholine receptors as targets for pain and inflammation: A focus on α7 nAChRs | en_US |
dc.type | Article | en_US |
dc.wos.quartile | Q1 | en_US |